Overview

Pharmacokinetics of Granule and Tablet Formulations of Deferitazole (Disodium Salt) and a Capsule Formulation of Deferitazole (Magnesium Hydroxide Salt)

Status:
Withdrawn

Trial end date:
2014-03-19

Target enrollment:

Participant gender:

Summary

The purpose of this study is to compare the pharmacokinetic profiles of deferitazole after administration of granule and tablet formulations of a deferitazole disodium salt to a capsule formulation of deferitazole magnesium hydroxide salt (reference formulation) in healthy adult subjects.

Phase:

Phase 1

Details

Lead Sponsor:

Shire

Treatments:

Magnesium Hydroxide